欧盟指控礼来(LLY.US)与诺和诺德(NVO.US)减肥药和降糖药存在麻醉后肺吸入风险

智通财经网07-12

智通财经获悉，欧洲卫生部门表示，如果即将接受手术的患者正在服用诺和诺德(NVO.US)和礼来(LLY.US)的降糖药和减肥药，应注意有出现麻醉并发症的风险。欧洲药品管理局安全委员会建议接受GLP-1药物治疗的患者在接受全身麻醉或深度镇静手术前告知医生，并表示产品信息将相应更新。该机构表示，在麻醉状态下服用此类药物的患者存在误吸胃内容物的“生物学上合理的风险”，尽管它没有发现“因果关系”。

欧盟去年要求包括诺和来和礼来在内的四家公司提供更多关于可能出现的麻醉并发症的信息，随后发布了最新指导意见。GLP-1药物包括诺和诺德公司的Wegovy和Ozempic，以及礼来公司的Mounjaro。美国麻醉师学会也在2023年6月发布了指导意见，建议患者在手术前跳过一剂药物。

潜在的风险是因为药物会延迟胃的排空，即使患者在手术前禁食，也有可能留下食物。胃里的液体进入肺部会使病人有患肺炎的危险。

更多港股重磅资讯，下载智通财经app

更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2450802185?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-12 20:56","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2450802185","market":"sh","top_or_hot":-1,"title":"欧盟指控礼来(LLY.US)与诺和诺德(NVO.US)减肥药和降糖药存在麻醉后肺吸入风险","media":"智通财经网","content":"<html><body><p>智通财经获悉，欧洲卫生部门表示，如果即将接受手术的患者正在服用<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>(NVO.US)和<a href=\"https://laohu8.com/S/LLY\">礼来</a>(LLY.US)的降糖药和减肥药，应注意有出现麻醉并发症的风险。欧洲药品管理局安全委员会建议接受GLP-1药物治疗的患者在接受全身麻醉或深度镇静手术前告知医生，并表示产品信息将相应更新。该机构表示，在麻醉状态下服用此类药物的患者存在误吸胃内容物的“生物学上合理的风险”，尽管它没有发现“因果关系”。</p><p>欧盟去年要求包括诺和来和礼来在内的四家公司提供更多关于可能出现的麻醉并发症的信息，随后发布了最新指导意见。GLP-1药物包括诺和诺德公司的Wegovy和Ozempic，以及礼来公司的Mounjaro。美国麻醉师学会也在2023年6月发布了指导意见，建议患者在手术前跳过一剂药物。</p><p>潜在的风险是因为药物会延迟胃的排空，即使患者在手术前禁食，也有可能留下食物。胃里的液体进入肺部会使病人有患肺炎的危险。</p><p>更多港股重磅资讯，下载智通财经app</p><p>更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)</p> </body></html>","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>欧盟指控礼来(LLY.US)与诺和诺德(NVO.US)减肥药和降糖药存在麻醉后肺吸入风险</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n欧盟指控礼来(LLY.US)与诺和诺德(NVO.US)减肥药和降糖药存在麻醉后肺吸入风险\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经网</strong><span class=\"h-time small\">2024-07-12 20:56</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经获悉，欧洲卫生部门表示，如果即将接受手术的患者正在服用<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>(NVO.US)和<a href=\"https://laohu8.com/S/LLY\">礼来</a>(LLY.US)的降糖药和减肥药，应注意有出现麻醉并发症的风险。欧洲药品管理局安全委员会建议接受GLP-1药物治疗的患者在接受全身麻醉或深度镇静手术前告知医生，并表示产品信息将相应更新。该机构表示，在麻醉状态下服用此类药物的患者存在误吸胃内容物的“生物学上合理的风险”，尽管它没有发现“因果关系”。</p><p>欧盟去年要求包括诺和来和礼来在内的四家公司提供更多关于可能出现的麻醉并发症的信息，随后发布了最新指导意见。GLP-1药物包括诺和诺德公司的Wegovy和Ozempic，以及礼来公司的Mounjaro。美国麻醉师学会也在2023年6月发布了指导意见，建议患者在手术前跳过一剂药物。</p><p>潜在的风险是因为药物会延迟胃的排空，即使患者在手术前禁食，也有可能留下食物。胃里的液体进入肺部会使病人有患肺炎的危险。</p><p>更多港股重磅资讯，下载智通财经app</p><p>更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)</p> </body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1150402.html\">智通财经网</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0154236417.USD","symbol_name":"BGF US FLEXIBLE EQUITY \"A2\" ACC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1150402.html","article_id":"2450802185","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2450802185","pubTimestamp":1720788976,"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经获悉，欧洲卫生部门表示，如果即将接受手术的患者正在服用诺和诺德和礼来的降糖药和减肥药，应注意有出现麻醉并发症的风险。欧洲药品管理局安全委员会建议接受GLP-1药物治疗的患者在接受全身麻醉或深度镇静手术前告知医生，并表示产品信息将相应更新。欧盟去年要求包括诺和来和礼来在内的四家公司提供更多关于可能出现的麻醉并发症的信息，随后发布了最新指导意见。胃里的液体进入肺部会使病人有患肺炎的危险。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0109391861.USD":"富兰克林美国机遇基金A Acc","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","BK4532":"文艺复兴科技持仓","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","LU0385154629.USD":"贝莱德营养科学基金A2","LU0079474960.USD":"联博美国增长基金A","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","BK4534":"瑞士信贷持仓","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","NVO":"诺和诺德","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC","BK4007":"制药","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BK4W5L77.USD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (USD) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU0471298694.HKD":"BGF NUTRITION \"A2\" (HKD) ACC","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU0122379950.USD":"贝莱德世界健康科学A2","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0882574139.USD":"富达环球消费行业基金A ACC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LLY":"礼来","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS"},"translate_title":"EU accuses Eli Lilly (LLY.US) and Novo Nordisk (NVO.US) of risk of pulmonary inhalation after anesthesia in weight loss and hypoglycemic drugs","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1,"LLY":1},"content_text":"智通财经获悉，欧洲卫生部门表示，如果即将接受手术的患者正在服用诺和诺德(NVO.US)和礼来(LLY.US)的降糖药和减肥药，应注意有出现麻醉并发症的风险。欧洲药品管理局安全委员会建议接受GLP-1药物治疗的患者在接受全身麻醉或深度镇静手术前告知医生，并表示产品信息将相应更新。该机构表示，在麻醉状态下服用此类药物的患者存在误吸胃内容物的“生物学上合理的风险”，尽管它没有发现“因果关系”。欧盟去年要求包括诺和来和礼来在内的四家公司提供更多关于可能出现的麻醉并发症的信息，随后发布了最新指导意见。GLP-1药物包括诺和诺德公司的Wegovy和Ozempic，以及礼来公司的Mounjaro。美国麻醉师学会也在2023年6月发布了指导意见，建议患者在手术前跳过一剂药物。潜在的风险是因为药物会延迟胃的排空，即使患者在手术前禁食，也有可能留下食物。胃里的液体进入肺部会使病人有患肺炎的危险。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2450802185"}